Helicobacter pylori of remnant stomach and optimal dose of amoxicillin for eradicating Helicobacter pylori

Hepato-Gastroenterology

Volumn 47, Issue 32, 2000, Pages 567-570

  Rino, Yasushi ^a   Imada, Toshio ^a   Shiozawa, Manabu ^a   Saeki, Hiroyuki ^a   Kabara, Takeshi ^a   Tanaka, Jun ichi ^a   Amano, Tomishige ^a   Kondo, Jiro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Eradication; Helicobacter pylori; Optimal dose of amoxicillin; Remnant gastritis; Remnant stomach

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; OMEPRAZOLE;

ADULT; AGED; ARTICLE; BODY WEIGHT; BREATH ANALYSIS; ERADICATION THERAPY; FEMALE; GASTRECTOMY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER; TIME;

AMOXICILLIN; ANTI-ULCER AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GASTRIC STUMP; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS;

EID: 0034001517     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 1 Kagawa S, Urakawa T, Nakayama Y, Tanaka T, Deguchi H, Kawai S, Takase N, Nagahata Y, Hayashi T, Saitoh Y: Comparative studies on operative procedures for gastroduodenal ulcer in view of late postoperative complications. J Jpn Soc Clin Surg 1984; 45:263-271.
2. 2 Burden WR, Hodges RP, Hsu M. Alkaline reflex gastritis. Surg Clin North Am 1991; 71:33-44.
3. 3 Warren JR, Marshall BJ: Unidentified curved bacilli gastric epithelium in active chronic gastritis. Lancet 1983; i:1273-1275.
4. 4 Feng Y, Waang Y: Campylobacter pylori in patients with gastritis, peptic ulcer, and carcinoma of the stomach in Lanzhou, China. Lancet 1988; i:1055-1056.
5. 5. Jiang SJ, Liu WZ, Zhang DZ, Shi Y, Xiao SD, Zhang ZH, Lu DY: Campylobacter-like organisms in chronic gastritis, peptic ulcer, and gastric carcinoma. Scand J Gastroenterol 1987; 22: 553-558.
6. 6 Kawakita N, Nagahata Y, Azumi Y, Wada T, Numata N, Saitoh Y: Residual gastritis after gastrectomy and helicobacter pyroli-Its clinical significance. J Jpn Gastroenterol 1995; 92:862-869.
7. 7 Spinzi GC, Sangiovanni A, Imperiali G, Terruzzi V, Minoli G, Baratelli G, Posca M, Scarpis M, Snider L: Prevention of duodenal ulcer relapse with amoxicillin and omeprazole. Eur J Gastroenterol Hepatol 1994; 6:599-602.
8. 8 Miehlke S, Bayerdorffer E, Lehn N, Mannes G, Sommer A, Hochter W, Weingart J, Hatz R, Ruckdeschel G, Dirschedl P, Stolte M: Two-year-follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin. Digestion 1995; 56:187-193.
9. 9 Imada T, Rino Y, Takehana T, Chin C, Suzuki M, Takahashi M, Morinaga S, Ozawa Y, Yamamoto Y, Amano T, Matsumoto A: Pylorus preserving gastrectomy for early gastric cancer. Surg Ther 1995; 73:377-383.
10. 10 Tatsuta M, Ishii H, Okuda S, Taniguchi H, Yokota Y: The association of helicobacter pylori with differentiated-type early gastric cancer. Cancer 1993; 72:1841-1845.
11. 11 Scott N, Lansdown M, Diament R, Rathbone B, Murday V, Wyatt JI, McMahon M, Dixon MF, Quirke P: Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet 1990; 728.
12. 12 Inoue H, Yamamoto I, Tanida N: Campylobacter pylori in Japan:bacteriological feature and prevalence in healthy subjects and patients with gastroduodenal disorders. Gastroenterol Jpn 1989; 24:494-504.
13. 13 Tanida N, Sakagami T, Nakamura Y, Kawaura A, Hikasa Y, Shimoyama T: Helicobacter pylori and gastric cancer. J Jpn Surg Soc 1996; 97:257-262.
14. 14 Nedrud JG, Czinn SJ: An update on Helicobacter pylori. Curr Opin Gastroenterol 1996; 12:62-67.
15. 15 Bell GD, Powell KU: Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scand J Gastroenterol 1993; 28:7-11.
16. 16 Nakamura K, Takahashi S, Igarashi H, Ishiyama N, Masubuchi N, Nakano M, Saito S, Aoyagi T, Yamagishi I, Ito T, Hirata I: Acid resistance of Helicobacter pylori. J J A Inf D 1993; 67:207-210.
17. 17 Lotterer E, Ludtke FE, Tegeler R, Bauer FE: The 13C-urease breath test, helicobacter pylori infection, and the operated stomach. J Clin Gastroenterol 1993; 16: 82-84.
18. 18 Raedsch R, Pohl S, Plachky J, Stiehl A, Kommerell B: The growth of Campylobacter pylori is inhibited by intragastric bile acids. In: Megraud F, Lamouliatte H (Eds.). Gastroduodenal pathology and Campylobacter pylori. Amsterdam: Excerpta Medica, 1989:pp409-142.
19. 19 Nagahata Y, Kawakita N, Azumi Y, Numata N, Yano M, Saitoh Y: Etiological involvement of Hericobacter pylori in "Reflux" gastritis after gastrectomy. Am J Gastroenterol 1996: 91:2130-2134.
20. 20 Glupezinski Y, Burette A, De Koster E, Nyst JF, Deltence M, Cadranel S et al: Metronidazole resistance in H. pylori. Lancet 1990; 1:976-977.
21. 21 Megraud F: H. pylori resistance to antibiotics. In: Hunt RH, Tytgat GNJ (Eds). Helicobacter pylori Basic mechanisms to clinical cure. Dordrecht/ Boston/London: Kluwer Academic Publishers 1993:570-583.
22. 22 Rokkas T, Mavrogergis A, Liatsos C, Rallis E, Kalogeropoulos N: Optimal dose of omeprazole in combination with amoxicillin in eradicating H. pylori and preventing relapses in duodenal ulcer patients. Hepatogastroenterology. 1995; 42:842-846.